blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0903348

EP0903348 - Epothilone derivatives and preparation thereof [Right-click to bookmark this link]
Former [1999/12]Epothilone derivatives, preparation and utilization
[2001/29]
StatusPatent maintained as amended
Status updated on  25.07.2008
Database last updated on 22.08.2024
Most recent event   Tooltip25.07.2008Patent maintained (B2 publication)published on 27.08.2008  [2008/35]
Applicant(s)For all designated states
Gesellschaft für Biotechnologische Forschung mbH (GBF)
Mascheroder Weg 1
D-38124 Braunschweig / DE
[2008/35]
Former [1999/12]For all designated states
Gesellschaft für Biotechnologische Forschung mbH (GBF)
Mascheroder Weg 1
D-38124 Braunschweig / DE
Inventor(s)01 / Höfle, Gerhard, Prof. Dr.
Mascheroder Weg 1
38124 Braunschweig / DE
02 / Kiffe, Michael, Dr.
Mascheroder Weg 1
38124 Braunschweig / DE
[1999/12]
Representative(s)Boeters, Hans Dietrich, et al
BOETERS & LIECK
Oberanger 32
80331 München / DE
[N/P]
Former [1999/12]Boeters, Hans Dietrich, Dr., et al
Patentanwälte Boeters & Bauer, Bereiteranger 15
81541 München / DE
Application number, filing date98121523.918.11.1996
[1999/12]
Priority number, dateDE199514298617.11.1995         Original published format: DE 19542986
DE199613945625.09.1996         Original published format: DE 19639456
[1999/12]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0903348
Date:24.03.1999
Language:DE
[1999/12]
Type: B1 Patent specification 
No.:EP0903348
Date:05.06.2002
Language:DE
[2002/23]
Type: B2 New European patent specification 
No.:EP0903348
Date:27.08.2008
Language:DE
[2008/35]
Search report(s)(Supplementary) European search report - dispatched on:EP27.01.1999
ClassificationIPC:C07D277/30, C07D417/06, C07D493/04, A61K31/425, A01N43/78, // (C07D493/04, 313:00, 303:00)
[1999/12]
CPC:
C07D417/06 (EP,US); A01N43/22 (EP,US); A01N43/78 (EP,US);
A01N43/90 (EP,US); A61P35/00 (EP); A61P37/00 (EP);
A61P37/06 (EP); C07D277/30 (EP,US); C07D493/04 (EP,US);
C07D493/08 (EP,US); C07F7/1804 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1999/12]
TitleGerman:Epothilon-Derivate und deren Herstellung[2001/29]
English:Epothilone derivatives and preparation thereof[2001/29]
French:Dérivés d'epothilone et leur préparation[2001/29]
Former [1999/12]Epothilon-Derivate, Herstellung und Verwendung
Former [1999/12]Epothilone derivatives, preparation and utilization
Former [1999/12]Dérivés d'epothilone, préparation et utilisation
Examination procedure16.11.1998Examination requested  [1999/12]
05.05.2000Despatch of a communication from the examining division (Time limit: M04)
04.09.2000Reply to a communication from the examining division
26.10.2000Despatch of a communication from the examining division (Time limit: M04)
27.02.2001Reply to a communication from the examining division
06.08.2001Despatch of communication of intention to grant (Approval: Yes)
11.12.2001Communication of intention to grant the patent
13.03.2002Fee for grant paid
13.03.2002Fee for publishing/printing paid
Parent application(s)   TooltipEP96939097.0  / EP0873341
Opposition(s)Opponent(s)01  04.03.2003  12.03.2003  WITHDRAWN
Sloan-Kettering Institute for Cancer Research
1275 York Avenue
10021 New York / US
Opponent's representative
Crooks, Elizabeth Caroline
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
 [N/P]
Former [2006/40]
Opponent(s)01  04.03.2003  12.03.2003  WITHDRAWN
Sloan-Kettering Institute for Cancer Research
1275 York Avenue
10021 New York / US
Opponent's representative
Crooks, Elizabeth Caroline
Kilburn & Strode 20 Red Lion Street
London WC1R 4PJ / GB
Former [2003/18]
Opponent(s)01  04.03.2003  12.03.2003  ADMISSIBLE
Sloan-Kettering Institute for Cancer Research
1275 York Avenue
10021 New York / US
Opponent's representative
King, Elizabeth Caroline
Kilburn & Strode 20 Red Lion Street
London WC1R 4PJ / GB
15.04.2003Invitation to proprietor to file observations on the notice of opposition
23.10.2003Reply of patent proprietor to notice(s) of opposition
25.02.2005Despatch of a communication from the opposition division (Time limit: M06)
25.02.2005Despatch of a communication from the opposition division (Time limit: M08)
25.02.2005Despatch of a communication from the opposition division (Time limit: M10)
25.08.2005Reply to a communication from the opposition division
05.01.2006Reply to a communication from the opposition division
01.09.2006Despatch of a communication from the opposition division (Time limit: M08)
03.05.2007Reply to a communication from the opposition division
08.06.2007Despatch of a communication from the opposition division (Time limit: M04)
08.10.2007Reply to a communication from the opposition division
26.11.2007Despatch of interlocutory decision in opposition
07.12.2007Legal effect of interlocutory decision in opposition
02.04.2008Despatch of communication that the patent will be maintained as amended
04.07.2008Fee for printing new specification paid
Fees paidRenewal fee
16.11.1998Renewal fee patent year 03
29.11.1999Renewal fee patent year 04
13.11.2000Renewal fee patent year 05
09.11.2001Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9310121  (BIOTECHNOLOG FORSCHUNG GMBH [DE], et al) [A] 1-5* the whole document *
Examination   - K.C.NICOLAOU et al. Angew.Chem.Int.Ed. 37 (1998) 2015-2045
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.